Evidence map›Paper›PMID 16011362›Full record

ArticleJournal of the American Chemical Society2005

Toward cocaine esterase therapeutics.

Claude J Rogers, Jenny M Mee, Gunnar F Kaufmann, Tobin J Dickerson, Kim D Janda

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Structural analysis of thermostabilizing mutations of cocaine esterase.Protein engineering, design & selection : PEDS · 2010
    Article
  4. PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity.Journal of controlled release : official journal of the Controlled Release Society · 2010
    Article
  5. Article
  6. Article
  7. Rational design of an enzyme mutant for anti-cocaine therapeutics.Journal of computer-aided molecular design · 2008
    Review
  8. Review
  9. Unexpected acetylcholinesterase activity of cocaine esterases.Journal of the American Chemical Society · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claude J RogersThe Skaggs Institute for Chemical Biology and Departments of Chemistry and Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Jenny M Mee
Gunnar F Kaufmann
Tobin J Dickerson
Kim D Janda

Funding

Immunopharmacotherapy for the Treatment of Cocaine AbuseR01DA008590 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI JANDA, KIM · 1994 to 2016
$6.4M
A new protein-based approach for cocaine abuse treatmentR21DA017228 · NIDA · SCRIPPS RESEARCH INSTITUTE · PI JANDA, KIM D · 2003 to 2004
$375k
NIDA NIH HHS DA 08590NIDA NIH HHS DA 17228NIDA NIH HHS R01 DA008590NIDA NIH HHS R21 DA017228
6 · The paper itself

Abstract

Cocaine is among the most reinforcing of all drugs of abuse, yet no effective pharmacotherapy is available. Herein, we report the development and characterization of phage-displayed cocaine esterases with pharmacologically relevant kinetic parameters (kcat/Km approximately 104 M-1 s-1).

Indexed as

Bacterial ProteinsBacteriophagesCarboxylic Ester HydrolasesCocaineEscherichia coliHydrolysisKineticsBacterial ProteinsCarboxylic Ester HydrolasesCocainecocaine esterase

Identifiers

PMID16011362
PMCPMC1352337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.